Challenged Healthcare Sector Could Offer Value via VFLO

Despite ongoing challenges in the healthcare sector, opportunities for value-oriented investors are emerging. The VictoryShares Free Cash Flow ETF (VFLO) is positioned to capitalize on this, tracking an index that selects undervalued companies with attractive growth prospects based on forward-looking free cash flow, exemplified by holdings like Cigna and Merck. This approach offers a strategic complement to growth-focused portfolios, identifying resilient companies within a sector poised for potential comeback despite regulatory and cost pressures.

Analysis

The healthcare sector is currently characterized by underperformance stemming from regulatory scrutiny and high costs, a reversal from its strong momentum that faded in late 2021. This environment is creating potential opportunities for value-focused investors. The VictoryShares Free Cash Flow ETF (VFLO) is positioned to capitalize on this theme by tracking an index with a forward-looking methodology. Specifically, the index screens for undervalued large-cap companies based on their *expected* free cash flow, rather than relying solely on historical data. This strategy, which calculates free cash flow yield against enterprise value, aims to identify firms with robust and growing cash flow generation capabilities, with Cigna and Merck cited as examples of its top holdings. While growth and momentum factors dominate the current market, the article suggests VFLO can serve as a valuable complement to growth-heavy portfolios, offering diversification away from concentrated mega-cap technology positions. Furthermore, a McKinsey & Company report indicates potential sector tailwinds from pharmaceutical and healthcare delivery innovations, which could support a future comeback for fundamentally sound healthcare names.

Key Decisions for Investors

• Investors with portfolios heavily weighted towards growth and technology stocks should consider VFLO as a diversifying agent to introduce the value factor and gain exposure to the U.S. large-cap healthcare space.
• For those looking to tactically allocate to the challenged healthcare sector, VFLO's strategy of focusing on forward free cash flow offers a selective approach, potentially identifying more resilient companies compared to broader market-cap weighted sector ETFs.
• It is prudent to monitor key sector catalysts, such as shifts in regulatory posture or breakthroughs in pharmaceutical innovation, as these could signal a broader recovery and act as significant tailwinds for VFLO's holdings.
• Before investing, one should evaluate if a factor-based strategy centered on free cash flow aligns with their risk profile, as such investments can experience periods of underperformance relative to the broader market, as noted in the fund's risk disclosures.